Introduction
Periodontal disease is an infectious disease of the structures surrounding the tooth, which results from complex interactions between plaque microorganisms and host immune system. It is one of the most prevalent In the recent years, the greatest of feats in biological sciences that is deciphering of human genome has given a new dimension to our understanding of various chronic immuno-inflammatory diseases, including periodontal disease. This has opened up new vistas of research in the field of medicine and dentistry. There is an exponential increase in the number of reports implicating an association between genes, genetic polymorphisms, and progression of periodontal disease.
Genetic factors are known to influence inflammatory and immune responses in periodontitis. As the immune system plays a crucial role in the pathogenesis of periodontitis, researchers have concentrated on the identification of genetic polymorphisms in several aspects of immunity. Allelic variants at multiple gene loci probably influence periodontitis susceptibility. The effects of some of these genetic variants may be large and of clinical significance, while the effects of others are probably minor and not clinically significant.
Genetic Disease Paradigms
Most human diseases have a genetic component to Tarannum and Faizuddin: Gene polymorphisms and periodontal diseases the etiology. The manner and extent to which genetic factors contribute to disease have important implications for identifying the genetic basis of aetiology and for utilizing this information for the diagnosis and treatment of the disease. Genetic diseases have been broadly classified into two groups: simple mendelian diseases and complex diseases. [1] Simple mendelian diseases (monogenic disorders) These are caused by a mutation in a single gene and are referred to as single gene (major gene effect) disorders. Inheritance patterns are autosomal dominant or of the autosomal recessive type. Severe periodontitis presents as part of the clinical manifestations of several monogenetic syndromes and the gene mutation and biochemical defect are known for many of these conditions. Various syndromes, which have periodontal disease manifestations as part of syndromic manifestations are Papillon Lefevre syndrome, Chediak-Higashi syndrome, Ehler-Danlos syndrome, cyclic neutropenia, and leukocyte adhesion deficiency. [1] Hereditary gingival fibromatosis is found to be associated with a mutation in the SOS (Son of Sevenless) gene. [2] The significance of these conditions is that they clearly demonstrate that a genetic mutation at a single locus can impart susceptibility to periodontitis.
Complex genetic diseases (polygenic disorders)
Genetically complex diseases are much more prevalent and usually occur with the frequency of greater than 1% of the population. Complex traits do not fit the typical inheritance patterns within families.
They are a result of the interaction of multiple different gene loci, environmental, and behavioural factors. Many of the diagnostic features of these complex diseases also called quantitative trait disorders are regulated by several genes. Periodontitis, which is the most common of the periodontal diseases, is considered to be a complex disease. Common features of complex human diseases (e.g., Alzheimer's disease, Crohn's disease, and cardiovascular disease) are that these conditions present mostly with a relatively mild phenotype and are slowly progressive and chronic in nature. [3] Various biological pathways leading to similar clinical phenomena characterise the patho-physiology of complex diseases.
Complex diseases are associated with variations in multiple genes, each having a small overall contribution and relative risk for the disease process. The clinical condition may not be evident unless two different genetic factors are present.
Inheritance of monogenic and complex (multifactorial) disorders
In monogenic diseases, mutations in a single gene are both necessary and sufficient to produce the clinical phenotype and to cause the disease. The impact of the gene on genetic risk for the disease is same in all families.
In complex disorders with multiple causes, variations in a number of genes encoding different proteins result in a genetic predisposition to a clinical phenotype.
Pedigrees reveal no Mendelian inheritance pattern, and gene mutations are often neither sufficient nor necessary to explain the disease phenotype. Environment and life-style are major contributors to the pathogenesis of complex diseases. In a given population, epidemiological studies expose the relative impact of individual genes on the disease phenotype. [4] However, between families the impact of these genes might be totally different. In one family, a rare gene C (family 3) might have a large impact on genetic predisposition to a disease. However, because of its rarity in the general population, the overall population effect of this gene would be small. Some genes that predispose individuals to disease might have minuscule effects in some families (gene D, Family 3) [ Figure 1 ].
Polymorphisms and mutations
A major difference in the genetic basis for simple Mendelian diseases and complex genetic diseases is the number of genes involved, and the contribution of each gene to the overall disease phenotype. The fact that the genetic alteration is predictably associated with a disease phenotype indicates that there is no redundancy or compensation in the particular biological system that can overcome the effect of the underlying genetic defect.
Such a genetic alteration is termed 'mutation' as in the case of Mendelian diseases.
The genetic alterations that contribute to complex diseases are individually of much smaller effect and are generally called 'generally polymorshims' because they are prevalent in the population. When a specific allele occurs, in at least 1% of the population, it is said to be genetic polymorphism. In contrast to mutations that have been casually linked with Mendelian diseases, genetic polymorphisms are often not directly casually linked, but rather specific alleles are reported to be found more frequently in diseased individuals than in non-affected controls. [5] 
Evidence for the role of genetic variants in periodontitis
Clinical and scientific data from a variety of sources suggest that the genetic variants are major determinants of syndromic and non-syndromic periodontitis. The evaluation of the quality of supporting studies requires an understanding of the formal genetic analytical methods that have been used.
Familial aggregation
Familial aggregation of a trait or disease can suggest genetic etiology. It results from shared genes, environmental exposures, and similar socioeconomic influences. There is literature reporting familial aggregation of periodontal diseases, but due to different terminology, classification systems and lack of standardized methods of clinical examination, it is difficult to compare reports directly. Most familial reports are for early-onset periodontitis (EOP) now called as aggressive periodontitis (AgP). [6] Twin studies twin studies have studied chronic periodontitis. [7] 
Segregation analysis
Genes segregate in families as predicted by Mendels laws. Segregation analysis is used to determine if trait transmission appears to fit a Mendelian or other mode of genetic transmission. Segregation analysis does not find a specific gene responsible for trait. Marazita and coworkers, 1994, performed the most definitive segregation analysis in North American families for aggressive periodontitis and found support for autosomal-dominant transmission with approximately 70% penetrance. [6] Linkage analysis Linkage analysis is a technique used to localize the gene for a trait to a specific chromosomal location. A specific trait can be followed as it segregates through families of interest and determine if the trait appears to segregate with a known genetic polymorphism. Linkage can prove the basis of disease. To date, linkage studies Maryland. [8] Hart et al., evaluated support for linkage in the region of chromosome 4 in a different population of families. [9] Association studies
Genes contributing to common, complex diseases such as periodontitis have proved to be more difficult to isolate.
A hypothetical example of the logic in play, in the study of gene polymorphism associations with the disease is:
in periodontitis (condition A), bone is lost (abnormality B) and since bone is removed by osteoclasts, which are influenced by a specific gene (gene C), the association of a known polymorphism (polymorphism D) of gene C periodontal diseases studies.
Two types of association analysis are commonly used:
population based and family based approaches.
Candidate genes for periodontal disease
The progression of periodontal disease is governed by the subject's host response, which is determined to some extent by previous experience (acquired immunity) but is predominantly influenced by the person's genetic make up. Thus, a range of genetic variations or deficiencies in the host response can increase the likelihood of periodontitis.
Several immune response traits have been associated
with clinical forms of periodontitis and some of these factors the underlying genetic determinants are known.
Although it is unlikely that polymorphisms in all these genetic determinants impart differential susceptibility to periodontal disease, it is reasonable to expect that multiple genes will be found to be important and that knowledge of these may permit determination of individual susceptibility. The key will be able to identify the genetic factors that are important enough to impart significant clinical risk.
In general, a gene may be considered as a candidate for a causative or modifying role in periodontitis if the physiological process determined by the genes has been associated with the presence or severity of disease.
Currently, little is known about which genes may be involved in periodontitis as disease modifying genes.
The table summarizes candidate gene polymorphisms investigated in relation to periodontitis [ Table 1 ].
Cytokine gene polymorphisms
Differences in the expression of cytokine are of great interest in periodontal research and this can be Immunoglobulin G2 HLADRB1
Human leukocyte antigen-DR HLADQB1
Human leukocyte antigen-DQ IFNGR1
Interferon ‫ﻻ‬receptor-1 IL1A
Interleukin-1α IL1B
Interleukin-1β IL1RN
Interleukin-1 receptor antagonist IL2
Interleukin-2 IL3
Interleukin-3 IL4
Interleukin-4 IL6
Interleukin-6 IL10
Interleukin-10 IL18
Inteleukin
Plasminogen-activator-inhibitor-1 PGHS [10] Frequency of allele 2 of the IL-1B +3953 SNP was significantly increased in patients with advanced periodontitis. [11, 12] Recently, a study tested polymorphisms derived from genes of the IL-1 cluster for association with generalized aggressive periodontitis (GAP) through both allelic association and by constructing a linkage disequilibrium map of the 2q13-14 disease candidate region. This study suggested that there is some evidence for an association between GAP and the IL-1β (+3953)
polymorphisms. [13] Currently, a genetic test is being marked for severe chronic periodontitis, called periodontal susceptibility test (PST). It tests for the presence of specific polymorphisms of the IL-1α and IL-1β genes. The genotype is determined from a finger stick blood or saliva samples.
Other cytokines
There is some preliminary evidence that genotype with respect to the IL-2 SNP might be associated with severity in aggressive periodontitis. [14] No significant difference was found in the frequency of IL-4 gene polymorphisms between control and periodontitis group in African-American-Brazilian population. [15] Analysis IL-6 gene polymorphisms in Czech patients with chronic periodontitis suggested that -572 G/C polymorphisms of IL-6 gene might be one of the protective factors associated with lower susceptibility to chronic periodontitis. [16] A study of the distribution of the genes related to IL-10 found no association between the genes for the cytokine and aggressive periodontitis compared with healthy controls. [17] Gonsales et al., investigated the influence of IL-10 promoter polymorphisms at position -824 and other at -597 on aggressive and chronic periodontitis and suggested that this polymorphism had no association with periodontal disease. [18] The frequency of genotypes at both positions was greater in moderate adult periodontitis. Six different IL-18 gene polymorphism (-656, -607, -137, +113, +127, and codon 35/3) were studied and none of the polymorphisms were associated with destructive periodontal disease. [19] Craandijk et al., found no significant association between a different series of four TNF-α gene polymorphisms and periodontitis patients. [20] Receptor gene polymorphisms
Fc‫ﻻ‬R gene polymorphisms
The polymorphism. NA1 is a more efficient opsonophagocytic agent than NA2. NA1 is found to a greater extent in Japanese patients who are resistant chronic periodontitis. [21] Meisel et al., analysed the association between Fc‫ﻻ‬R IIIa (high affinity receptor) and Fc‫ﻻ‬R
IIIb (low affinity receptor) and chronic periodontitis in
German population. They found that Fc‫ﻻ‬R IIIa was associated with chronic periodontitis but this is in linkage disequilibrium with Fc‫ﻻ‬R IIIb, which is also associated chronic periodontitis. [22] Toll-like receptor gene polymorphisms
Toll-like receptors are signal molecules essential for the cellular response to bacterial cell wall components. 
CD14 gene polymorphisms
The R-allele in the promoter region of CD14 at position -260(-159) enhances the transcriptional activity of the gene. [24] Two studies with Caucasian subjects investigated the CD14-260 polymorphism in chronic periodontitis, but did not find any significant associations. [25, 26] A higher frequency of the N -allele and the N/N genotype of CD14-1359 polymorphism was found in patients in severe periodontitis.
CARD15 gene polymorphisms
The 3020insC and 2104 C >T polymorphisms of the CARD15 (NOD2) gene leads to impaired activation of nuclear factor-kappa B, resulting in altered transcription of pro inflammatory cytokine genes and reduced expression of these cytokines. [27] No role for the CARD15 3020insC and 2104 C>T polymorphism was found for periodontitis in Caucasians. [28] Polymorphism of RANK gene RANKL and its receptor RANK have been implicated in increased rates of bone resorption in periodontal disease. Key mediators of osteoclast differentiation and activation, involve receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL), and osteoprotegrin (OPG). An association analysis with allelotypes showed that SNPs identified in the RANK/RANKL/OPG genes have no significant association with AgP in the Japanese population. [29] Vitamin D receptor gene polymorphisms Vitamin D receptor gene polymorphism has regulatory effects on bone mineral density and bone turnover.
Hennig et al., suggested that genotype of Taql VDR gene might be a risk indicator for susceptibility to EOP. [30] N-formyl peptide receptor polymorphisms
The high affinity FMLP receptor (FPR1) of phagocytic cells interacts with bacterial FMLP and mediates chemotaxis, degranulation, and superoxide production. P. gingivalis. [33] Polymorphisms in genes encoding enzymes
Cathepsin C gene polymorphism
Cathepsin C is a lysosomal protease present in neutrophils and macrophages as well as epithelial cells.
Hart and co-workers, 2000, identified and localized a gene on chromosome 11, which is responsible for a severe form of pre-pubertal periodontitis in a family of Jordanian descent. [34] Other mutations in the CTS C gene have been linked to the Papillon-Lefevre syndrome, a disease which is also associated with a severe form of pre-pubertal periodontitis. [35, 36] Therefore, certain functional CTS C gene mutation needs to be considered causative for pre-pubertal periodontitis (PPP). population. [37] Polymorphisms in cyclooxygenase-2 gene Prostaglandin E 2 (PGE 2 ) is considered to be an important mediator of tissue destruction in periodontitis.
Matrix metallo proteinase gene polymorphisms
Cyclooxygenase (COX) is known to catalyze the production of prostaglandins. COX-2, which is induced in an inflammatory response, is responsible for prostaglandin synthesis at sites of inflammation. Candidate genes in the chromosome 9q32-33 region include the gene for cyclooxygenase-2. A single nucleotide polymorphism of COX-2 −765 has been shown to alter the expression of the COX-2 gene. Ho et al., suggested that the −765G to C polymorphism of the COX-2 gene is associated with a decreased risk for periodontitis in Taiwanese, especially in AgP. [38] Polymorphisms in genes encoding for myeloperoxidase (MPO) bone loss was reported to be higher in the group with slow acetylator phenotype. [40] 
Polymorphisms in genes encoding vasoactive enzymes
The presence of lymphotoxin-α (TNF-β), angiotensinconverting enzyme (ACE) and endothelin-1 (ET-1) gene polymorphs were evaluated in Caucasian patients with adult periodontititis. Significant differences were reported with regard to three-locus combination of genotypes between diseased and healthy subjects. [41] 
Discussion

